MetaCap

Dare Bioscience (DARE) vs Quantum Biopharma (QNTM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Dare Bioscience (DARE) has outperformed Quantum Biopharma (QNTM) over the past year, losing 75.8% versus a loss of 77.6%. Over five years, DARE leads with a -98.1% price change compared with -98.5% for QNTM. Quantum Biopharma is the larger company by market cap ($8.3 million vs $8.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DARE-75.75%QNTM-77.60%
+107%+10%-86%
Nov 21, 20251 yearNov 20, 2026
DARE-97.97%QNTM-98.66%
+32%-36%-105%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DARE versus QNTM key metrics
MetricDAREQNTM
Share price$0.4074$1.29
Market cap$8.01M$8.29M
1-day change-9.87%-9.15%
YTD return-78.89%-82.33%
1-year return-75.75%-77.60%
5-year return-98.10%-98.51%
EPS (TTM)$-0.61$-3.42
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$1.03M—
Revenue growth (YoY)+10429.36%—
Net income (latest FY)$-13.40M—
Gross margin71.29%—
Operating margin-1315.51%—
Net margin-1300.66%—
52-week high$3.78$12.42
52-week low$0.406$1.26
Distance from 52-week high-89.22%-89.61%
Analyst consensusnonenone
Avg. price target upside+1944.67%+851.16%
Average volume242.39K148.83K
Shares outstanding19.67M6.43M
Employees21—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Dare Bioscience

DARE stock →

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees

About Quantum Biopharma

QNTM stock →

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments.

Health Care · Biotechnology: Pharmaceutical Preparations

DARE vs QNTM FAQ

Which is bigger, Dare Bioscience or Quantum Biopharma?

Quantum Biopharma (QNTM) is larger, with a market capitalization of $8.29M compared with $8.01M for Dare Bioscience (DARE).

Which stock has performed better over the past year, DARE or QNTM?

DARE returned -75.75% over the past 12 months, compared with -77.60% for QNTM (price return, excluding dividends). Past performance does not predict future results.

Are Dare Bioscience and Quantum Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons